PFM
GILD icon

Potomac Fund Management’s Gilead Sciences GILD Stock Holding History

Potomac Fund Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.26M Sell
16,210
-912
-5% -$128K 0.08% 29
2025
Q4 		$2.1M Sell
17,122
-1,817
-10% -$221K 0.08% 32
2025
Q3 		$2.1M Sell
18,939
-553
-3% -$62.9K 0.09% 33
2025
Q2 		$2.14M Sell
19,492
-964
-5% -$103K 0.12% 29
2025
Q1 		$2.13M Buy
20,456
+1,102
+6% +$114K 0.94% 10
2024
Q4 		$1.79M Buy
+19,354
New +$1.74M 0.1% 29

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Potomac Fund Management's GILD Position: Q1 2026 in Review

Potomac Fund Management reduced its Gilead Sciences (GILD) stake by 5.3% in Q1 2026, selling an estimated $128K and leaving 16,210 shares worth $2.26M. The position accounts for 0.08% of the portfolio, ranked #29.

Potomac Fund Management first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Potomac Fund Management held 16,210 shares of Gilead Sciences worth $2.26M as of Q1 2026.
  • Potomac Fund Management sold 912 Gilead Sciences shares in Q1 2026, an estimated $128K.
  • Gilead Sciences made up 0.08% of Potomac Fund Management's portfolio in Q1 2026, its #29 holding.
  • Potomac Fund Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Potomac Fund Management's 13F filing for Q1 2026, filed 14 May 2026.